AI assistant
DEXCOM INC — Director's Dealing 2025
May 12, 2025
30198_dirs_2025-05-12_4c6c7176-3378-44cc-af9e-3d531d2655eb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2025-05-08
Reporting Person: FOLETTA MARK G (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-08 | Common Stock | G | 2973 | — | Disposed | 0 | Direct |
| 2025-05-08 | Common Stock | G | 2973 | — | Acquired | 59371 | Indirect |
| 2025-05-08 | Common Stock | A | 5731 | — | Acquired | 5731 | Direct |
Footnotes
F1: Shares were transferred from direct ownership to ownership under the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, upon vesting of previously awarded restricted stock units.
F2: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.
F3: The RSU Award was granted on May 8, 2025 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.